Abstract: Technology creates a better visual perception of PMI data in a three dimensional representation of an object by adjusting the opacity of elements not normal to the view of the user.

Abstract: Technology is disclosed for improving the rendering of a three-dimensional (3D) object. In one aspect, the technology applies multi-scale visibility patches and adjacency heuristics to restore proper face and normals orientation at a per-object and per-polygon level; and target where best to apply ray-casting metrics to refine visibility determination.

Abstract: Technology creates a better visual perception of PMI data in a three dimensional representation of an object by adjusting the opacity of elements not normal to the view of the user.

Abstract: Disclosed are compounds of formula I: and the pharmaceutically acceptable salts thereof wherein the variables RN, R1, R2, R3, Rp and RC are defined herein. These compounds are useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal. The compounds of the invention are useful in pharmaceutical compositions and methods of treatment to reduce A beta peptide formation.

Abstract: Technology is disclosed for improving the rendering of a three-dimensional (3D) object. In one aspect, the technology applies multi-scale visibility patches and adjacency heuristics to restore proper face and normals orientation at a per-object and per-polygon level; and target where best to apply ray-casting metrics to refine visibility determination.

Abstract: Technology creates visualization data which corrects defects present in the native application data created by a CAD or other graphic application. A computer implemented process creates three dimensional object view data, and includes the steps of: accessing a three dimensional object data comprising a plurality of polygons having borders; building a border collapsion heap, the border collapsion heap comprising pairs of border elements separated by a distance; and joining one or more pairs of border elements based on a separation distance.

Abstract: The present invention relates to compound of formula (I), that are potent inhibitors of &agr;4&bgr;1 mediated adhesion to either VCAM or CS-1 and which could be useful for the treatment of inflammatory diseases. Specifically, the molecules of the present invention can be used for treating or preventing &agr;4&bgr;1 adhesion mediated conditions in a mammal such as a human. This method may comprise administering to a mammal or a human patient an effective amount of the compound or composition as explained in the present specification.